Sign In
Buy BIOVF
$48.21
+0 (+0%)
At Close: Jul 31, 2026
Swedish Orphan Biovitrum (BIOVF) Earnings Expected to Grow: Should You Buy?
11:02am, Tuesday, 11'th Jul 2023
Swedish Orphan Biovitrum (BIOVF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Swedish Orphan Biovitrum to acquire CTI BioPharma in a deal valued at $1.7 billion
02:26am, Wednesday, 10'th May 2023
Swedish Orphan Biovitrum AB SE:SOBI on Wednesday announced that it has entered into an agreement to acquire U.S.-based CTI BioPharma Corp. CTIC in a deal valued at $1.7 billion. The Stockholm-based dr
Sobi to acquire CTI BioPharma Corp. enhancing Sobi's position in rare haematology
01:32am, Wednesday, 10'th May 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTIO
Sobi to Acquire CTI BioPharma
01:06am, Wednesday, 10'th May 2023
Transaction Price of $9.10 Per Share Represents Compelling 89% Premium to CTI's Closing Stock Price on May 9, 2023 SEATTLE , May 10, 2023 /PRNewswire/ -- CTI BioPharma (Nasdaq: CTIC) ("CTI"), a commer
Swedish Orphan Biovitrum AB (publ) (BIOVF) Q1 2023 Earnings Call Transcript
10:58am, Saturday, 29'th Apr 2023
Swedish Orphan Biovitrum AB (publ) (OTCPK:BIOVF) Q1 2023 Earnings Conference Call April 27, 2023 8:00 AM ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financ
